Brain cancer remains one of medicine's most formidable challenges, requiring sophisticated treatment approaches tailored to ...
Investment analysts at StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCM – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback